Ibogaine by David Dardashti Explores Groundbreaking Research Linking Genetic Enhancers to Neurological Disease Treatment, Including Parkinson’s
Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...
Knowridge1d
Research shows a big hidden cause of Parkinson’s Disease
Scientists from the University of Rochester and other research centers have found a strong link between a widely used ...
BioTechniques7h
Novel enhancers linked to Parkinson’s and schizophrenia
A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
Gene Therapy: Revolutionizing Medicine By Tackling Diseases At Their Genetic Roots
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
Global study identifies markers for the five clinical stages of Parkinson's disease
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
Parkinson’s Disease: The long-awaited early detection technique is on the horizon
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
SHINE9h
Shanghai hospital experts detect new target to slow Parkinson's disease
Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.
PMLiVE1d
FDA grants RMAT designation to AskBio’s Parkinson’s gene therapy candidate
The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to AskBio’s investigational Parkinson’s disease (PD) gene therapy. The FDA grants RMAT ...
Pharmabiz1d
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...
The Pharma Letter2d
AskBio wins FDA RMAT designation for Parkinson’s gene therapy
Germany-based Bayer’s wholly-owned gene therapy company AskBio today announced that its investigational gene therapy AB-1005 ...